Inventor · disambiguated record
Jonathan Morris
Also filed as: MORRIS JONATHAN · MORRIS JONATHAN CHARLES
12 granted patents·1 pending application·30 citations·filing 2001–2024
87Inventor score
Top patents by PatentIndex Score
13 records- 0190US12024504B21-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseasesEXONATE LTD·Filed 2022·Granted Jul 2, 2024·1 cites·3 claims
- 0286US11180521B2Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereofMETRO INT BIOTECH LLC·Filed 2019·Granted Nov 23, 2021·7 cites·19 claims
- 0384US7772241B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2009·Granted Aug 10, 2010·5 cites·25 claims
- 0475US7495000B2Variolin derivatives and their use as antitumor agentsPHARMA MAR SA·Filed 2002·Granted Feb 24, 2009·7 cites·36 claims
- 0573US12325704B2SRPK1 inhibitorsEXONATE LTD·Filed 2022·Granted Jun 10, 2025·0 cites·9 claims
- 0673US2024300929A11-methyl-1h-pyrazol-3-yl derivatives for use in the treatment of neovascular diseasesEXONATE LTD·Filed 2024·Application pending·0 cites
- 0772US7320981B2Variolin derivatives as anti-cancer agentsPHARMA MAR SA·Filed 2001·Granted Jan 22, 2008·8 cites·45 claims
- 0869US9695160B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2015·Granted Jul 4, 2017·1 cites·20 claims
- 0963US10301264B2Compounds useful for treating ocular neovasculanUNIV NOTTINGHAM·Filed 2013·Granted May 28, 2019·1 cites·9 claims
- 1061US11420969B2SRPK1 inhibitorsEXONATE LTD·Filed 2018·Granted Aug 23, 2022·0 cites·33 claims
- 1157US9932330B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2017·Granted Apr 3, 2018·0 cites·20 claims
- 1256US9796707B2Piperazine derivatives for treating disordersUNIV NOTTINGHAM·Filed 2017·Granted Oct 24, 2017·0 cites·20 claims
- 1341US10696661B2CompoundsEXONATE LTD·Filed 2016·Granted Jun 30, 2020·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →